27
War & Conflict4h 1m ago

Gland Pharma Limited’s Board approved the re-appointment of Mr. Udo Johannes Vetter and the appointment of Mr. William Robert Keller as Independent Directors, effective June 15, 2026, following the resignation of Mr. Satyanarayana Murthy Chavali.

Archive Window: 7 Days Left

not specified

Who
Gland Pharma Limited, Mr. Udo Johannes Vetter, Mr. William Robert Keller, Mr. Satyanarayana Murthy Chavali, Mr. Essaji Goolam Vahanvati, Sampath Kumar Pallerlamudi
What
Gland Pharma Limited’s Board approved the re-appointment of Mr. Udo Johannes Vetter and the appointment of Mr. William Robert Keller as Independent Directors, effective June 15, 2026, following the resignation of Mr. Satyanarayana Murthy Chavali.
When
Mon, 15 Jun 2026 21:48:44 GMT · 4h 1m ago
Where
not specified ·
Why
Mr. Satyanarayana Murthy Chavali resigned due to a potential conflict of interest arising from a company where he is a Promoter and Director proposing to enter a business segment overlapping with Gland Pharma’s future activities.
The Frontline Impact

How this affects you

The leadership change at Gland Pharma due to a director's conflict of interest and the appointment of new independent directors could influence the company's strategic direction and compliance, potentially affecting investor confidence and market perception of its governance.

Story chain

3 events in this thread

Verified Sources & Citations